- Report
- June 2024
- 200 Pages
Global
From €7593EUR$7,950USD£6,349GBP
- Report
- June 2024
- 200 Pages
Global
From €7593EUR$7,950USD£6,349GBP
- Report
- June 2024
- 200 Pages
Global
From €7593EUR$7,950USD£6,349GBP
- Report
- May 2024
- 132 Pages
Global
From €6207EUR$6,499USD£5,190GBP
- Report
- May 2024
- 128 Pages
Global
From €6207EUR$6,499USD£5,190GBP
- Report
- March 2025
- 89 Pages
Global
From €5348EUR$5,600USD£4,472GBP
- Report
- May 2024
- 134 Pages
Global
From €6207EUR$6,499USD£5,190GBP
- Report
- May 2024
- 135 Pages
Global
From €6207EUR$6,499USD£5,190GBP
- Report
- March 2025
- 184 Pages
Global
From €4298EUR$4,500USD£3,594GBP
- Report
- February 2025
- 185 Pages
Global
From €4298EUR$4,500USD£3,594GBP
- Report
- January 2025
- 180 Pages
Global
From €4298EUR$4,500USD£3,594GBP
- Report
- August 2024
- 185 Pages
Global
From €4298EUR$4,500USD£3,594GBP
- Report
- January 2025
- 250 Pages
Global
From €4774EUR$4,999USD£3,992GBP
- Report
- June 2022
- 150 Pages
Global
From €5682EUR$5,950USD£4,752GBP
- Report
- April 2022
- 250 Pages
Asia Pacific
From €2378EUR$2,490USD£1,989GBP
From €3343EUR$3,500USD£2,795GBP
- Report
- September 2022
- 239 Pages
Global
From €7163EUR$7,500USD£5,990GBP
- Report
- September 2022
- 116 Pages
Global
From €3772EUR$3,950USD£3,155GBP
- Report
- January 2022
- 60 Pages
Global
From €3772EUR$3,950USD£3,155GBP
- Report
- November 2021
- 156 Pages
Global
From €6638EUR$6,950USD£5,551GBP

The Human Papillomavirus (HPV) is a virus that can cause a variety of cancers, including cervical, anal, and oropharyngeal cancers. In the oncology market, HPV-related treatments are used to treat these cancers, as well as to prevent them from occurring in the first place. HPV vaccines are used to prevent infection with the virus, while treatments such as chemotherapy and radiation therapy are used to treat HPV-related cancers. Additionally, targeted therapies such as immunotherapy and monoclonal antibodies are used to treat HPV-related cancers.
In the HPV market, there are a number of companies that are involved in the development and manufacture of treatments and vaccines. These include Merck, GlaxoSmithKline, Sanofi, Pfizer, and AstraZeneca. Additionally, there are a number of smaller companies that are involved in the development of treatments and vaccines for HPV-related cancers. Show Less Read more